PMGC HOLDINGS INC. Interest Expense
PMGC HOLDINGS INC. (ELAB) reported Interest Expense of $19.52 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-03-29
- PMGC HOLDINGS INC. interest expense for the quarter ending 2023-12-31 was -$12.74M.
- PMGC HOLDINGS INC. interest expense for the quarter ending 2023-09-30 was $5.71M, a 784.37% increase year-over-year.
- PMGC HOLDINGS INC. interest expense for the quarter ending 2022-12-31 was -$2.63M.
- PMGC HOLDINGS INC. interest expense for the quarter ending 2022-09-30 was $646.00K.
- PMGC HOLDINGS INC. interest expense for fiscal 2023 was $19.52K, a 642.68% increase from fiscal 2022.
- PMGC HOLDINGS INC. interest expense for fiscal 2022 was $2.63K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$12.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$7.03M derived: sum of 2 quarters · filed 2024-03-29 | $19.52K 10-K · filed 2024-03-29 | |
| 2023-09-30 | $5.71M 10-Q · filed 2023-12-11 | $12.76M 10-Q · filed 2023-12-11 | ||
| 2022-12-31 | -$2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$1.98M derived: sum of 2 quarters · filed 2024-03-29 | $2.63K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $646.00K 10-Q · filed 2023-12-11 | $2.63M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |